MDAI Spectral AI, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1833498 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-37.6%
TTM net income YoY37.7%
TTM EPS YoY60.0%
Revenue 3-yr CAGR-8.5%
Net income 3-yr CAGR—
Margins
Gross margin39.9%
Operating margin-86.5%
Net margin-70.5%
FCF margin—
EBITDA margin-85.7%
Returns
ROE—
ROA-64.0%
ROIC (approx.)—
Asset turnover0.91x
Leverage & solvency
Liabilities / assets193.2%
Debt / equity—
Current ratio0.63x
Interest coverage-6.86x
Cash quality & payout
Operating cash flow / net income1.28x
Accruals ratio17.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.86M | $3.52M | $3.99M | $4.09M | $3.79M | $5.07M | $6.71M | $7.60M |
| Cost of revenue | $2.08M | $2.41M | $1.96M | $2.24M | $2.17M | $2.77M | $3.54M | $4.26M |
| Gross profit | $778,000 | $1.11M | $2.03M | $1.85M | $1.62M | $2.29M | $3.17M | $3.35M |
| R&D expense | $1.99M | $1.70M | $2.00M | — | $1.53M | $1.46M | $3.60M | — |
| SG&A expense | $2.34M | $3.09M | $4.00M | $4.09M | $3.06M | $2.62M | $4.06M | $4.46M |
| Operating income | -$3.97M | -$4.32M | -$1.97M | -$2.24M | -$3.34M | -$2.12M | -$896,000 | -$1.11M |
| Interest expense | $586,000 | $378,000 | $258,000 | $602,000 | $164,000 | $120,000 | $20,000 | — |
| Pretax income | -$3.73M | -$4.01M | -$3.42M | $1.01M | -$3.55M | -$7.99M | $2.97M | -$7.60M |
| Income tax | -$78,000 | $170,000 | -$10,000 | -$43,000 | $2,000 | -$19,000 | $71,000 | $143,000 |
| Net income | -$3.66M | -$4.18M | -$3.41M | $1.05M | -$3.55M | -$7.97M | $2.90M | -$7.74M |
| EBITDA | -$3.94M | -$4.29M | -$1.94M | -$2.21M | -$3.31M | -$2.11M | -$894,000 | -$1.11M |
| EPS (basic) | -0.11 | -0.13 | -0.11 | — | -0.13 | -0.31 | 0.13 | — |
| EPS (diluted) | -0.11 | -0.13 | -0.11 | — | -0.13 | -0.31 | 0.11 | — |
| Weighted avg. shares (diluted) | 32.18M | 32.08M | 31.76M | — | 26.32M | 25.42M | 24.03M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $11.20M | $14.00M | $11.70M | $15.40M | $10.49M | $10.52M | $14.06M | $5.16M |
| Receivables | $1.31M | $1.18M | $1.19M | $1.27M | $990,000 | $1.47M | $2.10M | $2.50M |
| Inventory | $932,000 | $815,000 | $831,000 | $838,000 | $454,000 | $462,000 | $437,000 | $425,000 |
| Current assets | $15.13M | $17.79M | $15.99M | $19.45M | $13.46M | $14.00M | $18.73M | $10.12M |
| PP&E, net | $168,000 | $198,000 | $228,000 | $258,000 | $287,000 | $317,000 | $164,000 | $2,000 |
| Total assets | $16.56M | $19.44M | $17.73M | $21.41M | $15.30M | $16.01M | $20.72M | $12.10M |
| Current liabilities | $24.19M | $19.87M | $21.27M | $20.63M | $15.77M | $16.19M | $13.31M | $17.64M |
| Short-term debt | $800,000 | $800,000 | — | — | — | — | — | — |
| Long-term debt | $7.44M | $11.05M | $4.50M | $5.54M | $6.58M | $7.63M | $7.51M | $2.79M |
| Total debt | $8.24M | $11.86M | $4.50M | $5.54M | $6.58M | $7.63M | $7.51M | $2.79M |
| Total liabilities | $31.99M | $31.49M | $26.54M | $27.13M | $23.50M | $25.16M | $22.35M | $19.35M |
| Shareholders' equity | -$15.43M | -$12.05M | -$8.81M | -$5.73M | -$8.20M | -$9.15M | -$1.63M | -$7.25M |
| Net debt | -$2.96M | -$2.15M | -$7.20M | -$9.86M | -$3.91M | -$2.89M | -$6.55M | -$2.37M |
| Shares outstanding | 32.18M | 32.18M | 31.82M | 30.69M | 27.25M | 25.74M | 25.59M | 22.59M |
| Cash flow statement | ||||||||
| Operating cash flow | -$2.65M | -$4.10M | -$3.73M | -$2.55M | -$2.50M | -$3.36M | -$1.50M | $469,000 |
| Financing cash flow | -$109,000 | $6.42M | -$1,000 | $7.45M | $2.48M | -$207,000 | $10.39M | $1.01M |
| Depreciation & amortization | $30,000 | $30,000 | $30,000 | $29,000 | $30,000 | $10,000 | $2,000 | $3,000 |
| Stock-based compensation | $276,000 | $807,000 | $183,000 | $243,000 | $261,000 | $411,000 | $200,000 | $174,000 |
Free plan shows the latest 8 periods; Pro shows all 23 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.